Scientific article
English

Hybrid PET-MRI in Alzheimer's Disease Research

Published in

Methods in Molecular Biology, vol. 1750, p. 185-200

Publication date

2018

Abstract

Multiple factors, namely amyloid, tau, inflammation, metabolic, and perfusion changes, contribute to the cascade of neurodegeneration and functional decline occurring in Alzheimer's disease (AD). These molecular and cellular processes and related functional and morphological changes can be visualized in vivo by two imaging modalities, namely positron emission tomography (PET) and magnetic resonance imaging (MRI). These imaging biomarkers are now part of the diagnostic algorithm and of particular interest for patient stratification and targeted drug development.In this field the availability of hybrid PET/MR systems not only offers a comprehensive evaluation in a single imaging session, but also opens new possibilities for the integration of the two imaging information. Here, we cover the clinical protocols and practical details of FDG, amyloid, and tau PET/MR imaging as applied in our institutions.

Citation (ISO format)

MAINTA, Ismini Charis et al. Hybrid PET-MRI in Alzheimer’s Disease Research. In: Methods in Molecular Biology, 2018, vol. 1750, p. 185–200. doi: 10.1007/978-1-4939-7704-8_12

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1064-3745
605views
1downloads

Technical informations

Creation

12/05/2018 20:19:00

First validation

12/05/2018 20:19:00

Update

13/10/2025 19:09:22

Status update

15/03/2023 08:15:51

Last indexation

04/11/2026 12:41:44
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated